ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: However, at the TKI era, CML patients can reach clinical remission, cytogenetic remission, and molecular remission during which Ph-positive clone or BCR-ABL fusion is undetectable, making this strategy impractical.